AdaptHealth Corp. (NASDAQ:AHCO) Given Average Recommendation of “Moderate Buy” by Analysts

AdaptHealth Corp. (NASDAQ:AHCOGet Free Report) has been assigned a consensus rating of “Moderate Buy” from the six analysts that are presently covering the stock, MarketBeat reports. One equities research analyst has rated the stock with a hold rating and five have given a buy rating to the company. The average 12-month price objective among analysts that have covered the stock in the last year is $12.17.

AHCO has been the topic of several analyst reports. Canaccord Genuity Group dropped their price target on shares of AdaptHealth from $14.00 to $13.00 and set a “buy” rating on the stock in a research report on Wednesday, November 6th. UBS Group cut their price target on AdaptHealth from $13.00 to $12.00 and set a “buy” rating for the company in a research note on Wednesday, November 6th. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $13.00 price target on shares of AdaptHealth in a report on Monday, August 12th. Finally, Robert W. Baird dropped their price objective on AdaptHealth from $16.00 to $14.00 and set an “outperform” rating on the stock in a report on Wednesday, November 6th.

Get Our Latest Research Report on AdaptHealth

Insider Buying and Selling

In other AdaptHealth news, COO Shaw Rietkerk sold 25,000 shares of the stock in a transaction that occurred on Friday, September 20th. The stock was sold at an average price of $11.24, for a total transaction of $281,000.00. Following the completion of the transaction, the chief operating officer now owns 212,611 shares of the company’s stock, valued at $2,389,747.64. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. In related news, Director David Solomon Williams III sold 4,000 shares of the business’s stock in a transaction dated Thursday, August 29th. The shares were sold at an average price of $11.26, for a total transaction of $45,040.00. Following the transaction, the director now directly owns 36,899 shares in the company, valued at approximately $415,482.74. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, COO Shaw Rietkerk sold 25,000 shares of the stock in a transaction dated Friday, September 20th. The shares were sold at an average price of $11.24, for a total transaction of $281,000.00. Following the completion of the sale, the chief operating officer now owns 212,611 shares of the company’s stock, valued at approximately $2,389,747.64. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. 4.43% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in AHCO. Janney Montgomery Scott LLC lifted its position in AdaptHealth by 80.1% during the first quarter. Janney Montgomery Scott LLC now owns 27,949 shares of the company’s stock worth $322,000 after buying an additional 12,430 shares in the last quarter. Texas Permanent School Fund Corp raised its holdings in shares of AdaptHealth by 1.4% during the 1st quarter. Texas Permanent School Fund Corp now owns 71,201 shares of the company’s stock worth $820,000 after acquiring an additional 979 shares during the period. Empowered Funds LLC boosted its position in shares of AdaptHealth by 8.2% during the 1st quarter. Empowered Funds LLC now owns 502,762 shares of the company’s stock valued at $5,787,000 after acquiring an additional 38,084 shares during the last quarter. SG Americas Securities LLC acquired a new position in shares of AdaptHealth during the 1st quarter valued at about $129,000. Finally, Sei Investments Co. purchased a new stake in shares of AdaptHealth in the first quarter valued at about $2,365,000. 82.67% of the stock is currently owned by institutional investors and hedge funds.

AdaptHealth Stock Performance

Shares of AHCO stock opened at $10.09 on Wednesday. AdaptHealth has a 52-week low of $6.43 and a 52-week high of $11.90. The company has a quick ratio of 0.94, a current ratio of 1.24 and a debt-to-equity ratio of 1.34. The stock has a market cap of $1.36 billion, a PE ratio of -6.12, a price-to-earnings-growth ratio of 1.58 and a beta of 1.11. The business has a 50-day simple moving average of $10.70 and a 200-day simple moving average of $10.45.

AdaptHealth (NASDAQ:AHCOGet Free Report) last announced its quarterly earnings results on Tuesday, November 5th. The company reported $0.15 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.17 by ($0.02). The company had revenue of $805.90 million during the quarter, compared to analyst estimates of $809.32 million. AdaptHealth had a negative net margin of 6.57% and a positive return on equity of 9.62%. The company’s revenue was up .2% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.19 earnings per share. On average, equities analysts expect that AdaptHealth will post 0.87 EPS for the current year.

About AdaptHealth

(Get Free Report

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.

See Also

Analyst Recommendations for AdaptHealth (NASDAQ:AHCO)

Receive News & Ratings for AdaptHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AdaptHealth and related companies with MarketBeat.com's FREE daily email newsletter.